A representative picture of the file. | Photo Credit: Sushil Kumar Verma
The High Court in Delhi canceled criminal proceedings against Nicholas Piramal India Ltd. (Now Piramal Enterprises Ltd.) and its managers in a two -year alleged false case of the children’s cough Tixylix, which was not submitted against them.
The case arose from a complaint filed by the Delhi government department for drug control and claims that samples of syrup collected in 2002 from Delhi distributor failed quality tests.
In 2003, it stated that the “not standard quality” sample, in 2003, GHAZIABAD, GHAZIABAD, GHAZIABAD, GHAZIABAD, GHAZIABAD. On this basis, a complaint was filed in February 2004 and pre -summons were issued against the supplier chain – from retailers to distributors to manufacturers.
The manufacturer was challenged by the court court and the session by court orders that refused to release them in a complaint filed under the Drug and Cosmetics Act (D&C).
Piramal, represented by the leader of attorney PUNEET MITTAL, attacked the Ghaziabad report and claimed that the laboratory was not equipped to carry out the necessary test according to the law and the rules of D&C, due to the unavailability of the prescribed methods.
Mr. Mittal also pointed out a subsequent test in the Laboratory of Government Analyst in Vadodar in Gujarat at the same dose that certified the drug from standard quality.
The High Court noted on August 28 that there were two contradictory government laboratory reports at the same dose, saying: “It is a settled law that if there are two opinions from documents collected/created during the investigation, the one who benefits the accused must prevail.”
The court also recorded procedural violations because the drug inspector failed to send a copy of the GHAZIABAD report and the sealed sample to the manufacturer, as entrusted with the D&C law.
“With regard to the above discussion, it is therefore decided that there is no case of Prima Facia in the complaint,” the court said at the release of the petitioners.
Read more
Published – August 30, 2025 17:29
